Francis Cano is Director at BIOMERICA INC (BMRA). They have made 9 open-market trades across 3 companies since 2007, most recently 2026-02-10.
CIK 0001286710
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
6 open-market purchases totalling $210K since 2007, against 3 sales. Across 5 scored buys the stock is down 9.1% at ninety days, and 7.8 points behind the S&P over the same stretch.
5 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 40% | 40% | 20% |
| Avg Move | -4.8% | +0.5% | -9.1% |
| Alpha | -3.0% | +0.4% | -7.8% |
| Scored | 5 | 5 | 5 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| DVAX | SELL | 2024-05-31 | 2024-06-03 | $11.93 | $43K | -1.3% | -9.4% | -10.6% |
| DVAX | SELL | 2022-08-08 | 2022-08-10 | $17.17 | $515K | -31.9% | -32.4% | -27.7% |
| DVAX | BUY | 2019-08-12 | 2019-08-12 | $3.00 | $50K | +24.3% | +35.5% | +58.1% |
| DVAX | SELL | 2018-12-06 | 2018-12-07 | $10.47 | $21K | -11.2% | -4.4% | -20.3% |
| BMRA | BUY | 2018-01-24 | 2018-01-25 | $4.18 | $49K | +0.7% | +11.7% | -12.9% |
| BMRA | BUY | 2016-08-08 | 2016-08-10 | $2.63 | $12K | -23.1% | -23.1% | -48.2% |
| BMRA | BUY | 2016-08-04 | 2016-08-05 | $2.37 | $39K | -23.1% | -20.1% | -40.5% |
| DVAX | BUY | 2011-08-05 | 2011-08-08 | $2.54 | $51K | -2.9% | -1.7% | -1.7% |
| BMRA.OB | BUY | 2007-05-25 | 2007-07-12 | $0.74 | $9K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.